Kernodle & Katon Asset Management Group’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$107K Hold
446
0.06% 125
2016
Q4
$94K Hold
446
0.06% 130
2016
Q3
$103K Hold
446
0.06% 135
2016
Q2
$103K Hold
446
0.1% 87
2016
Q1
$120K Hold
446
0.11% 67
2015
Q4
$139K Buy
+446
New +$133K 0.13% 41

Other funds holding AGN

Kernodle & Katon Asset Management Group's AGN Position: Q1 2017 in Review

Kernodle & Katon Asset Management Group held its Allergan plc (AGN) position steady in Q1 2017 at 446 shares worth $107K. The position accounts for 0.06% of the portfolio, ranked #125.

Kernodle & Katon Asset Management Group first reported a position in AGN in Q4 2015 and has held it in 6 quarters since. The position peaked at $139K in Q4 2015. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.

  • Kernodle & Katon Asset Management Group held 446 shares of Allergan plc worth $107K as of Q1 2017.
  • Kernodle & Katon Asset Management Group left its Allergan plc share count unchanged in Q1 2017.
  • Allergan plc made up 0.06% of Kernodle & Katon Asset Management Group's portfolio in Q1 2017, its #125 holding.
  • Kernodle & Katon Asset Management Group first reported a position in Allergan plc in Q4 2015 and has held it in 6 quarters since.
  • Kernodle & Katon Asset Management Group's Allergan plc position peaked at $139K in Q4 2015.
  • 1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on Kernodle & Katon Asset Management Group's 13F filing for Q1 2017, filed 12 May 2017.